Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-12 4:30 pm Sale |
2024-12-31 | 13G | CAVA Group, Inc. CAVA |
Artal Participations S.a r.l | 9,507,990 8.300% |
-8,000,000![]() (-45.69%) |
Filing History |
2024-11-12 4:32 pm Sale |
2024-09-30 | 13G | CAVA Group, Inc. CAVA |
Artal Participations S.a r.l | 17,507,990 15.300% |
-14,500,000![]() (-45.30%) |
Filing History |
2024-07-12 6:23 pm Sale |
2024-07-12 | 13G | Korro Bio, Inc. KRRO |
Artal Participations S.a r.l | 413,072 4.500% |
-5,533![]() (-1.32%) |
Filing History |
2024-07-12 6:17 pm Sale |
2024-07-12 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal Participations S.a r.l | 116,155 4.300% |
-22,800![]() (-16.41%) |
Filing History |
2024-07-12 6:12 pm Purchase |
2024-07-12 | 13G | Cartesian Therapeutics, Inc. RNAC |
Artal Participations S.a r.l | 594,940 2.800% |
246,412![]() (+70.70%) |
Filing History |
2024-07-08 6:51 pm Purchase |
2023-06-01 | 13G | HOOKIPA Pharma Inc. HOOK |
Artal Participations S.a r.l | 566,641 5.900% |
466,142![]() (+463.83%) |
Filing History |
2024-03-29 4:30 pm Sale |
2024-03-29 | 13G | Achilles Therapeutics plc ACHL |
Artal Participations S.a r.l | 755,375 1.900% |
-1,500,000![]() (-66.51%) |
Filing History |
2024-03-29 4:30 pm Unchanged |
2024-03-29 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 1,811,191 4.900% |
0 (Unchanged) |
Filing History |
2024-02-09 5:16 pm Sale |
2023-12-31 | 13G | Aptinyx Inc. APTX |
Artal Participations S.a r.l | 0 0.000% |
-6,116,493![]() (Position Closed) |
Filing History |
2024-02-09 5:14 pm Sale |
2023-12-31 | 13G | Aravive, Inc. ARAV |
Artal Participations S.a r.l | 7,609,522 9.400% |
-4,572,515![]() (-37.53%) |
Filing History |
2024-02-09 5:14 pm Purchase |
2023-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Artal Participations S.a r.l | 12,834,446 17.400% |
2,279,168![]() (+21.59%) |
Filing History |
2024-02-09 5:13 pm Purchase |
2023-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Artal Participations S.a r.l | 348,528 6.400% |
8,295![]() (+2.44%) |
Filing History |
2024-02-09 5:13 pm Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 1,811,191 5.000% |
-432,161![]() (-19.26%) |
Filing History |
2024-02-09 5:12 pm Purchase |
2023-12-31 | 13G | AlloVir, Inc. ALVR |
Artal Participations S.a r.l | 286,833 5.800% |
44,348![]() (+18.29%) |
Filing History |
2024-02-09 5:11 pm Purchase |
2023-12-31 | 13G | IGM Biosciences, Inc. IGMS |
Artal Participations S.a r.l | 3,100,422 9.400% |
650,422![]() (+26.55%) |
Filing History |
2024-02-09 5:11 pm Sale |
2023-12-31 | 13G | Agenus Inc. AGEN |
Artal Participations S.a r.l | 781,562 4.100% |
-14,850![]() (-1.86%) |
Filing History |
2024-02-09 5:10 pm Purchase |
2023-12-31 | 13G | SQZ Biotechnologies Company SQZB |
Artal Participations S.a r.l | 1,141,309 3.900% |
980,678![]() (+610.52%) |
Filing History |
2024-02-09 5:09 pm Purchase |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Artal Participations S.a r.l | 2,038,870 9.900% |
1,804,126![]() (+768.55%) |
Filing History |
2024-02-09 5:08 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal Participations S.a r.l | 3,568,842 9.900% |
2,105,013![]() (+143.80%) |
Filing History |
2024-02-09 5:08 pm Sale |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Artal Participations S.a r.l | 0 0.000% |
-15,066,043![]() (Position Closed) |
Filing History |